Understanding the Legal Risks of BPC 157 and Other Unapproved Peptides Holt Law The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York fda warning bpc 157 peptide products New Details 157 A Note on Peptides by Shantanu Out of Singapore FDA takes first step in possible reversal of ban on some peptides The Washington Post